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Wuotations From
nticipated Coronary
eart Disease Mortality Trends
n a recent editorial published in the Journal, Greenland and Lloyd-
ones (1) commented on coronary heart disease mortality trends in the
.S. (2). They quoted an editorial by Brown and Goldstein (3) by
tating that these authors were “proclaiming the ‘end of heart attacks
y the century.’ ” The original editorial by Brown and Goldstein (3)
recisely stated that “recent breakthroughs . . . may well end coronary
isease as a major public health problem early in the next century.”
rown and Goldstein were also said to predict “that current knowl-
dge, if fully applied, could end heart attacks within a short time” (1).
rown and Goldstein (3) did not proclaim the end of heart attacks
nd used vague language (“may”) to stress the speculative nature of
heir beliefs. The eye-catching title of Brown and Goldstein’s editorial
Heart Attacks: Gone With the Century?” (3) is formulated as a
uestion only. Furthermore, if the incidence, mortality, adverse
uality of life, and high costs of coronary heart disease were markedly
iminished and no longer a major public health problem, this would
ot necessarily imply that heart attacks would no longer occur.
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enomics of Aortic Valve Disease
read with great interest the recent article by Bossé et al. (1) that
ummarized the molecular mechanisms underlying calcific aortic
alve disease, the genetic epidemiology of calcific aortic valve
isease, and advances in genomic approaches and their applications oo elucidating calcific aortic valve disease. Indeed, recent studies
ave indicated that calcific aortic valve disease is influenced by
enetic factors, and the article provided a succinct review of the
iterature. However, the authors may have “overstated” their
ssertion that there are no other heritability or inheritance studies
hat have reported on calcific aortic valve disease other than those
eporting on the bicuspid aortic valve. Using an affected sibpair
esign, we performed genome-wide linkage analysis in African-
merican and white hypertensive sibships participating in the
ypertension Genetic Epidemiology Network Study and found
trong evidence of linkage of aortic valve sclerosis to chromosome
6q22.1–q22.3 (logarithm of odds [LOD] score 3.1) (2). There
as also suggestive evidence of linkage of aortic valve sclerosis to
hromosome 19p13.11–p11 (LOD score 2.88), another position
n chromosome 16q22.1–q22.3 (LOD score 2.63), chromosome
q42 (LOD score  2.12), and chromosome 2q37 (LOD score 
.03). The presence of multiple peaks in several chromosomal
egions suggests pleiotropy in susceptibility genes predisposing to
ortic valve sclerosis. The study extended the report from Probst et
l. (3) that showed clusters of families affected by aortic valve
tenosis and that also indicated that offspring of affected individ-
als had aortic valve sclerosis, suggesting that aortic valve sclerosis
ay be an early manifestation of familial aortic valve stenosis.
urther studies are underway to identify the specific genes con-
ained in these novel chromosomal regions we found in the study
hat are responsible for the observed linkage results. Although the
dentification of genes influencing calcific aortic valve disease is
hallenging, it offers much promise in defining novel mechanistic
aradigms and developing therapeutic strategies in the prevention
nd treatment of calcific aortic valve disease.
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eply
e appreciate the precision comments by Dr. Bella concerning
ur recent review on the genetics/genomics of calcific aortic valve
